People who are newly diagnosed with knee or hip osteoarthritis continue to take non-steroidal anti-inflammatory drugs (NSAIDs) despite contraindications, a new study shows. A team from Boston ...

Skylar Clarine is a fact-checker and expert in personal finance with a range of experience including veterinary technology and film studies. New indications is a term pharmaceutical companies use to ...

While off-label use may be permissible, contraindicated use still has a strong regulatory boundary as reinforced by FDA guidance finalized in 2025.